文献速递妇幼与学校卫生免疫规划传染病防控与疫情报告

评估既往母亲黄热病疫苗接种与寨卡病毒产前暴露后婴儿不良结局保护之间的潜在关联

Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure.
PubMed 文献 · Int J Epidemiol · 2025-01-01

该病例队列研究于2018至2022年在巴西大坎普开展,纳入129对确诊宫内寨卡病毒暴露的母婴及匹配对照组,检测母亲寨卡暴露与黄热病疫苗中和抗体滴度。结果显示,寨卡暴露与未暴露母亲、以及小头畸形与非小头畸形儿童母亲之间黄热病中和抗体滴度存在差异,先天性异常与较低黄热病中和抗体滴度相关;神经发育迟缓与产前寨卡暴露、产前检查次数较少及小于胎龄儿相关。

要点

  • 寨卡暴露与未暴露母亲、小头畸形与非小头畸形儿童母亲之间黄热病中和抗体滴度存在差异。
  • 先天性异常与较低黄热病中和抗体滴度、产前寨卡暴露及较低家庭收入相关。
  • 神经发育迟缓与产前寨卡暴露、产前检查至少6次及适龄或大于胎龄出生体重相关。

核心结论

  • 母亲黄热病中和抗体滴度随寨卡暴露和小头畸形状态不同而存在差异,提示黄热病疫苗接种对寨卡病毒获得和/或小头畸形发展可能有潜在保护作用,应予研究。
  • 发育迟缓虽与母亲黄热病免疫无关,但与产前寨卡暴露、较少产前检查次数及小于胎龄儿相关。

研究设计与样本

  • 病例队列研究,2018至2022年在巴西大坎普开展,纳入确诊宫内寨卡病毒暴露儿童(2015-2018年)及匹配对照组,共129对母婴。
  • 采集母亲血样评估寨卡病毒暴露和黄热病疫苗诱导的中和抗体滴度。
  • 评估黄热病中和抗体滴度与先天性异常及婴儿神经发育迟缓之间的关联。

主要发现

  • 寨卡暴露与未暴露母亲的平均黄热病中和抗体滴度存在差异(P = .011)。
  • 小头畸形儿童与无小头畸形儿童母亲的平均黄热病中和抗体滴度存在差异(P = .037)。
  • 先天性异常与较低黄热病中和抗体滴度(P < .001)、产前寨卡暴露(P = .001)及较低家庭收入(P < .001)相关。
  • 神经发育迟缓与产前寨卡暴露相关(aOR:4.35,95%CI:1.65-13.03)。
  • 神经发育迟缓与产前检查至少6次相关(aOR:0.22,95%CI:0.06-0.78),与适龄或大于胎龄出生体重相关(aOR:0.09,95%CI:0.01-0.44)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the Zika virus (ZIKV) epidemic in Brazil, regional disparities in yellow fever (YF) vaccination coverage and microcephaly incidence led to the hypothesis that maternal YF vaccination could protect against ZIKV infection and microcephaly. METHODS: This case-cohort study was conducted in Campo Grande, Brazil, from 2018 to 2022 and included children with confirmed in utero ZIKV exposure (2015-2018) and a matched control group, totaling 129 mother-child dyads. Maternal blood samples were collected to assess ZIKV exposure and neutralizing YF vaccine-induced antibody (NAb) titers. Associations between YF NAb titer, congenital anomalies, and infant neurodevelopmental delay were evaluated. RESULTS: Mean YF NAb titers differed between ZIKV-exposed and unexposed mothers (P = .011) and between mothers of children with and without microcephaly (P = .037). Congenital anomalies were associated with lower YF NAb titers (P < .001), prenatal ZIKV exposure (P = .001), and lower family income (P < .001). Neurodevelopmental delay was associated with prenatal ZIKV exposure [adjusted odds ratio (aOR): 4.35, 95% confidence interval (CI): 1.65-13.03], prenatal care with at least six visits (aOR: 0.22, CI: 0.06-0.78), and adequate or large for gestational age birth weight (aOR: 0.09, CI: 0.01-0.44). CONCLUSION: Differences in maternal YF NAb titers by ZIKV exposure and microcephaly suggest a potential protective effect of YF vaccination against ZIKV acquisition and/or development of microcephaly, which should be investigated. Developmental delay, although not associated with maternal YF immunity, was associated with antenatal ZIKV exposure, less prenatal care visits, and being small for gestational age.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Oliveira EF, Santos-Pinto CDB, Venancio FA, et al. Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure. Int J Epidemiol. 2025. PMID: 40825594. doi:10.1093/ije/dyaf147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。